Smruthi Organics [SMRUTHIORG] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Smruthi Organics Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Smruthi Organics Ltd. wins in 7 metrics, Sun Pharmaceutical Industries Ltd. wins in 13 metrics, with 0 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Smruthi Organics Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 29.60 36.73 Smruthi Organics Ltd.
Price-to-Book Ratio 1.91 5.15 Smruthi Organics Ltd.
Debt-to-Equity Ratio 13.16 6.68 Sun Pharmaceutical Industries Ltd.
PEG Ratio -5.46 3.59 Sun Pharmaceutical Industries Ltd.
EV/EBITDA 10.49 23.61 Smruthi Organics Ltd.
Profit Margin (TTM) 4.14% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 10.45% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 10.45% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 4.97% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 3.19% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-15.39M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield 2.45% 0.97% Smruthi Organics Ltd.
1-Year Return -4.34% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 1.22 7.05 Smruthi Organics Ltd.
Enterprise Value $1.39B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 1.25 6.66 Smruthi Organics Ltd.
Gross Profit Margin (TTM) 70.32% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $97 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $4.01 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) -0.24 0.11 Smruthi Organics Ltd.

Smruthi Organics Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

SMRUTHIORG
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Smruthi Organics Ltd.0.85%-3.64%2.54%-5.82%-3.21%2.19%
Sun Pharmaceutical Industries Ltd.0.12%-0.94%-2.12%-0.13%-1.28%3.55%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Smruthi Organics Ltd.-4.34%-14.68%-52.59%-2.06%-9.72%74.81%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Smruthi Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSMRUTHIORGSUNPHARMA
Market Information
Market Cap i₹1.36B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i3,5933,903,142
90 Day Avg. Volume i4,1093,253,866
Last Close₹119.00₹1,782.20
52 Week Range₹95.00 - ₹164.00₹1,548.00 - ₹1,916.60
% from 52W High-27.44%-7.01%
All-Time High₹419.35 (Jul 12, 2021)₹1,960.35 (Sep 30, 2024)
% from All-Time High-71.62%-9.09%
Growth Metrics
Quarterly Revenue Growth-0.29%0.14%
Quarterly Earnings Growth-0.06%0.16%
Financial Health
Profit Margin (TTM) i0.04%0.19%
Operating Margin (TTM) i0.10%0.26%
Return on Equity (TTM) i0.05%0.15%
Debt to Equity (MRQ) i13.166.68
Cash & Liquidity
Book Value per Share (MRQ)₹61.99₹324.46
Cash per Share (MRQ)₹1.04₹115.87
Operating Cash Flow (TTM) i₹195.06M₹110.84B
Levered Free Cash Flow (TTM) i₹35.63M₹109.29B
Dividends
Last 12-Month Dividend Yield i2.45%0.97%
Last 12-Month Dividend i₹3.00₹16.50

Valuation & Enterprise Metrics Analysis: Smruthi Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSMRUTHIORG (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i29.6036.73
Forward P/E iN/A29.48
PEG Ratio i-5.463.59
Price to Sales (TTM) i1.227.05
Price to Book (MRQ) i1.915.15
Market Capitalization
Market Capitalization i₹1.36B₹3.88T
Enterprise Value i₹1.39B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i1.256.66
Enterprise to EBITDA i10.4923.61
Risk & Other Metrics
Beta i-0.240.11
Book Value per Share (MRQ) i₹61.99₹324.46

Financial Statements Comparison: Smruthi Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSMRUTHIORG (2025)SUNPHARMA (2025)
Revenue/Sales i1.25B520.41B
Cost of Goods Sold i709.72M121.98B
COGS % of Revenue i56.9%23.4%
Gross Profit i537.81M398.44B
Gross Margin i43.1%76.6%
Research & Development i9.24MN/A
Operating Income (EBIT) i66.81M125.81B
Operating Margin i5.4%24.2%
EBITDA i118.84M167.25B
EBITDA Margin i9.5%32.1%
Pre-Tax Income i49.00M137.52B
Pre-Tax Income % of Revenue i3.9%26.4%
Income Tax i13.37M27.72B
Income Tax % of Revenue i1.1%5.3%
Net Income (Profit) i35.63M109.65B
Profit Margin i2.9%21.1%

Balance Sheet & Liquidity Metrics

MetricSMRUTHIORG (2025)SUNPHARMA (2025)
Cash & Equivalents i4.36M102.69B
Total Current Assets i633.33M526.24B
Total Current Assets % of Revenue i50.8%101.1%
Total Current Liabilities i310.76M181.94B
Total Current Liabilities % of Revenue i24.9%35.0%
Long-Term Debt i81.62M3.58B
Long-Term Debt % of Revenue i6.5%0.7%
Total Shareholders Equity i716.29M724.86B
Retained Earnings i583.25M578.62B
Retained Earnings % of Revenue i46.8%111.2%
Property, Plant & Equipment i110.00M100.36B

Cash Flow Statement Comparison

MetricSMRUTHIORG (2025)SUNPHARMA (2025)
Operating Cash Flow i195.06M110.84B
Operating Cash Flow % of Revenue i15.6%21.3%
Capital Expenditures i-115.15M-20.68B
Free Cash Flow i-15.39M119.44B
FCF Margin i-1.2%23.0%
Debt Repayment i-16.83M-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricSMRUTHIORGSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i11.45M2.40B
Float Shares i3.82M1.07B
% Held by Insiders i66.91%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i33.09%15.69%

Dividend Analysis & Yield Comparison: Smruthi Organics Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSMRUTHIORGSUNPHARMA
Last 12-Month Dividend i₹3.00₹16.50
Last 12-Month Dividend Yield i2.45%0.97%
3-Year Avg Annual Dividend i₹3.33₹17.33
3-Year Avg Dividend Yield i1.43%0.51%
3-Year Total Dividends i₹10.00₹52.00
Ex-Dividend DateJun 13, 2025Feb 05, 2026